Indications for: TOPICORT SPRAY
≥18yrs: apply thin film to affected areas twice daily for up to max 4 weeks; discontinue when control is achieved. Do not occlude.
<18yrs: not recommended.
TOPICORT SPRAY Warnings/Precautions:
Avoid use on eyes, face, axilla, or groin. Do not use on pre-existing skin atrophy. Risk of HPA axis suppression with high-potency steroids, prolonged use, application to large surface area, use of occlusive dressings, altered skin barrier, liver failure, young age; discontinue gradually, reduce dose, or substitute with less potent corticosteroid if occurs. Cataracts. Glaucoma. Treat infection if present; discontinue if infection persists until resolved. Flammable. Avoid abrupt cessation in chronic use. Reevaluate periodically. Pregnancy. Nursing mothers: avoid direct infant exposure.
TOPICORT SPRAY Classification:
TOPICORT SPRAY Interactions:
Avoid concomitant with other corticosteroid-containing products.
Application site dryness, irritation and pruritus; allergic contact dermatitis (discontinue if irritation occurs), HPA axis suppression (esp. in children); rare: Cushing's syndrome, hyperglycemia.
Generic Drug Availability: